Center for Public Health Genomics (R.A., A.A., J.H., L.C., J.Y.S., D.L., E.F., R.A.-W., N.A., A.W.M., S.O.-G., C.L.M., M.C.), University of Virginia, Charlottesville.
CVPath Institute, Inc, Gaithersburg, MD (L.G., D.F., A.F.).
Circ Res. 2020 Dec 4;127(12):1552-1565. doi: 10.1161/CIRCRESAHA.120.317415. Epub 2020 Oct 12.
Coronary artery disease (CAD) is a major cause of morbidity and mortality worldwide. Recent genome-wide association studies revealed 163 loci associated with CAD. However, the precise molecular mechanisms by which the majority of these loci increase CAD risk are not known. Vascular smooth muscle cells (VSMCs) are critical in the development of CAD. They can play either beneficial or detrimental roles in lesion pathogenesis, depending on the nature of their phenotypic changes.
To identify genetic variants associated with atherosclerosis-relevant phenotypes in VSMCs.
We quantified 12 atherosclerosis-relevant phenotypes related to calcification, proliferation, and migration in VSMCs isolated from 151 multiethnic heart transplant donors. After genotyping and imputation, we performed association mapping using 6.3 million genetic variants. We demonstrated significant variations in calcification, proliferation, and migration. These phenotypes were not correlated with each other. We performed genome-wide association studies for 12 atherosclerosis-relevant phenotypes and identified 4 genome-wide significant loci associated with at least one VSMC phenotype. We overlapped the previously identified CAD loci with our data set and found nominally significant associations at 79 loci. One of them was the chromosome 1q41 locus, which harbors . The G allele of the lead risk single nucleotide polymorphism (SNP) rs67180937 was associated with lower VSMC expression and lower proliferation. Lentivirus-mediated silencing of MIA3 (melanoma inhibitory activity protein 3) in VSMCs resulted in lower proliferation, consistent with human genetics findings. Furthermore, we observed a significant reduction of MIA3 protein in VSMCs in thin fibrous caps of late-stage atherosclerotic plaques compared to early fibroatheroma with thick and protective fibrous caps in mice and humans.
Our data demonstrate that genetic variants have significant influences on VSMC function relevant to the development of atherosclerosis. Furthermore, high expression may promote atheroprotective VSMC phenotypic transitions, including increased proliferation, which is essential in the formation or maintenance of a protective fibrous cap.
冠心病(CAD)是全球发病率和死亡率的主要原因。最近的全基因组关联研究揭示了 163 个与 CAD 相关的位点。然而,大多数这些位点增加 CAD 风险的确切分子机制尚不清楚。血管平滑肌细胞(VSMCs)在 CAD 的发展中至关重要。它们在病变发病机制中可以发挥有益或有害的作用,这取决于其表型变化的性质。
鉴定与 VSMCs 中动脉粥样硬化相关表型相关的遗传变异。
我们量化了从 151 位多民族心脏移植供体中分离的 VSMCs 中与钙化、增殖和迁移相关的 12 个动脉粥样硬化相关表型。在基因分型和内插后,我们使用 630 万个遗传变异进行了关联作图。我们证明了钙化、增殖和迁移的显著差异。这些表型彼此不相关。我们对 12 个动脉粥样硬化相关表型进行了全基因组关联研究,并鉴定了与至少一种 VSMC 表型相关的 4 个全基因组显著位点。我们将先前鉴定的 CAD 位点与我们的数据集中的 79 个具有名义显著关联的位点进行了重叠。其中之一是 1q41 染色体上的位点,它包含. 风险单核苷酸多态性(SNP)rs67180937 的 G 等位基因与 VSMC 中的 表达降低和增殖降低相关。在 VSMCs 中,慢病毒介导的 MIA3(黑色素瘤抑制活性蛋白 3)沉默导致增殖降低,与人类遗传学发现一致。此外,我们观察到在小鼠和人类中,与早期纤维粥样瘤相比,晚期动脉粥样硬化斑块中的薄纤维帽中 VSMCs 的 MIA3 蛋白表达显著降低,早期纤维粥样瘤的纤维帽较厚且具有保护作用。
我们的数据表明,遗传变异对与动脉粥样硬化发展相关的 VSMC 功能有显著影响。此外,高 表达可能促进了保护性的 VSMC 表型转变,包括增殖增加,这对于形成或维持保护性纤维帽至关重要。